What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Rheumatologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
D Scott Cunningham MD, PhD
Site Editor, MDLinx
MMP-3 and COMP predict PsA response to TNF inhibitors
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
921 New studies back effectiveness of hospitalists Full Text American Medical News , September 8, 2004
922 Rare gout manifestation of head and neck Otolaryngology Head and Neck Surgery, September 1, 2004
923 Addressing musculoskeletal pain Geriatrics, August 16, 2004
924 Hospitals are laying the groundwork for EMRs Full Text American Medical News , August 3, 2004
925 Report Details How New Hospitals Should Look, Function Full Text Nursing Spectrum, July 21, 2004
926 AHA: protect hospitals affected by the PPS rules labor market changes Full Text American Hospital Association News, July 14, 2004
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryIn a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryIn a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summary1 Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality QJM: An International Journal of Medicine, April 11, 2013
2 New developments in gout Current Opinion in Rheumatology, March 29, 2013
3 Gout, stone composition and urinary stone risk: a matched case comparative study The Journal of Urology, April 4, 2013
4 Ultrasound learning curve in gout: A disease-oriented training programme Arthritis Care & Research , April 1, 2013
5 Role of Interleukin-1 Inhibitors in the Management of Gout Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 5, 2013
6 Urate lowering therapies: an overview Journal de Pharmacie Clinique, March 25, 2013
7 A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study Annals of Rheumatic Diseases, April 8, 2013
8 Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study Annals of Rheumatic Diseases, April 10, 2013
9 Uric Acid Levels Correlate with Baseline Renal Function and High Levels are a Potent Risk Factor for Postoperative Chronic Kidney Disease in Patients with Renal Cell Carcinoma The Journal of Urology, April 16, 2013
10 Italian Society of Rheumatology recommendations for the management of gout Rheumatismo, April 3, 2013 Free full text
11 A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia Annals of Rheumatic Diseases, April 9, 2013 Evidence Based Medicine
12 New classification criteria for gout: a framework for progress Rheumatology, April 24, 2013
13 Management of Gouty Arthritis in Patients With Chronic Kidney Disease American Journal of Therapeutics, March 27, 2013
14 Allopurinol Hypersensitivity Reactions: Desensitization Strategies and New Therapeutic Alternative Molecules Inflammation & Allergy - Drug Targets, April 12, 2013
15 Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: an ultrasonographic study Annals of Rheumatic Diseases, April 11, 2013
16 Lipid-Associated Rheumatologic Syndromes Rheumatic Disease Clinics of North America, April 23, 2013 Review Article
17
Understanding the dose-response relationship of allopurinol: predicting the optimal dosage
British Journal of Clinical Pharmacology, April 22, 2013
Exclusive Author Commentary
18 Hyperuricemia, and nutritional ways to approach it Journal de Pharmacie Clinique, March 21, 2013
19 Primary care providers knowledge, beliefs and treatment practices for gout: results of a physician questionnaire Rheumatology, April 29, 2013
20 Gout treatment: should we aim for rapid crystal dissolution Annals of Rheumatic Diseases, April 8, 2013
Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close